Basilea subject of takeover speculation
Basilea, the listed, Swiss pharmaceuticals group, is considered to be a takeover candidate, Tagesanzeiger reported. The Swiss daily noted repeated market speculation which has led the Basilea share to gain 4.7%.
The original article appeared in print on page 43.
Tagesanzeiger